Altered CB1 receptor and endocannabinoid levels precede motor symptom onset in a transgenic mouse model of Huntington's disease

Battista, 2007, Severe deficiency of the fatty acid amide hydrolase (FAAH) activity segregates with the Huntington's disease mutation in peripheral lymphocytes, Neurobiol Dis, 27, 108, 10.1016/j.nbd.2007.04.012 Bisogno, 2008, Symptom-related changes of endocannabinoid and palmitoylethanolamide levels in brain areas of R6/2 mice, a transgenic model of Huntington's disease, Neurochem Int, 52, 307, 10.1016/j.neuint.2007.06.031 Bradshaw, 2006, Sex and hormonal cycle differences in rat brain levels of pain-related cannabimimetic lipid mediators, Am J Physiol Regul Integr Comp Physiol, 291, R349, 10.1152/ajpregu.00933.2005 Centonze, 2005, Abnormal sensitivity to cannabinoid receptor stimulation might contribute to altered gamma-aminobutyric acid transmission in the striatum of R6/2 Huntington's disease mice, Biol Psychiatry, 57, 1583, 10.1016/j.biopsych.2005.03.008 Cepeda, 2003, Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington's disease, J Neurosci, 23, 961, 10.1523/JNEUROSCI.23-03-00961.2003 Cepeda, 2004, Increased GABAergic function in mouse models of Huntington's disease: reversal by BDNF, J Neurosci Res, 78, 855, 10.1002/jnr.20344 Cha, 1999, Altered neurotransmitter receptor expression in transgenic mouse models of Huntington's disease, Philos Trans R Soc Lond B Biol Sci, 354, 981, 10.1098/rstb.1999.0449 Cha, 1998, Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human Huntington disease gene, Proc Natl Acad Sci U S A, 95, 6480, 10.1073/pnas.95.11.6480 Denovan-Wright, 2000, Cannabinoid receptor messenger RNA levels decrease in a subset of neurons of the lateral striatum, cortex and hippocampus of transgenic Huntington's disease mice, Neuroscience, 98, 705, 10.1016/S0306-4522(00)00157-3 Egertova, 2003, Comparative analysis of fatty acid amide hydrolase and cb(1) cannabinoid receptor expression in the mouse brain: evidence of a widespread role for fatty acid amide hydrolase in regulation of endocannabinoid signaling, Neuroscience, 119, 481, 10.1016/S0306-4522(03)00145-3 Faull, 1993, The distribution of GABAA-benzodiazepine receptors in the basal ganglia in Huntington's disease and in the quinolinic acid-lesioned rat, Prog Brain Res, 99, 105, 10.1016/S0079-6123(08)61341-2 Glass, 2001, The role of cannabinoids in neurodegenerative diseases, Prog Neuropsychopharmacol Biol Psychiatry, 25, 743, 10.1016/S0278-5846(01)00162-2 Glass, 2000, The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease, Neuroscience, 97, 505, 10.1016/S0306-4522(00)00008-7 Glass, 1993, Loss of cannabinoid receptors in the substantia nigra in Huntington's disease, Neuroscience, 56, 523, 10.1016/0306-4522(93)90352-G Glass, 2004, Delayed onset of Huntington's disease in mice in an enriched environment correlates with delayed loss of cannabinoid CB1 receptors, Neuroscience, 123, 207, 10.1016/S0306-4522(03)00595-5 Herkenham, 1990, Cannabinoid receptor localization in brain, Proc Natl Acad Sci U S A, 87, 1932, 10.1073/pnas.87.5.1932 Hickey, 2002, The role of dopamine in motor symptoms in the R6/2 transgenic mouse model of Huntington's disease, J Neurochem, 81, 46, 10.1046/j.1471-4159.2002.00804.x Ho, 2001, The molecular biology of Huntington's disease, Psychol Med, 31, 3, 10.1017/S0033291799002871 Hockly, 2002, Environmental enrichment slows disease progression in R6/2 Huntington's disease mice, Ann Neurol, 51, 235, 10.1002/ana.10094 1993, A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes, Cell, 72, 971, 10.1016/0092-8674(93)90585-E Kofalvi, 2005, Involvement of cannabinoid receptors in the regulation of neurotransmitter release in the rodent striatum: a combined immunochemical and pharmacological analysis, J Neurosci, 25, 2874, 10.1523/JNEUROSCI.4232-04.2005 Lastres-Becker, 2002, Loss of mRNA levels, binding and activation of GTP-binding proteins for cannabinoid CB1 receptors in the basal ganglia of a transgenic model of Huntington's disease, Brain Res, 929, 236, 10.1016/S0006-8993(01)03403-5 Lastres-Becker, 2001, Changes in endocannabinoid transmission in the basal ganglia in a rat model of Huntington's disease, Neuroreport, 12, 2125, 10.1097/00001756-200107200-00017 Laviolette, 2006, The roles of cannabinoid and dopamine receptor systems in neural emotional learning circuits: implications for schizophrenia and addiction, Cell Mol Life Sci, 63, 1597, 10.1007/s00018-006-6027-5 Lopez-Moreno, 2008, The pharmacology of the endocannabinoid system: functional and structural interactions with other neurotransmitter systems and their repercussions in behavioral addiction, Addict Biol, 13, 160, 10.1111/j.1369-1600.2008.00105.x Maccarrone, 2007, The endocannabinoid pathway in Huntington's disease: a comparison with other neurodegenerative diseases, Prog Neurobiol, 81, 349, 10.1016/j.pneurobio.2006.11.006 Mangiarini, 1996, Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice, Cell, 87, 493, 10.1016/S0092-8674(00)81369-0 Matsuda, 1993, Localization of cannabinoid receptor mRNA in rat brain, J Comp Neurol, 327, 535, 10.1002/cne.903270406 Mazarakis, 2005, Deficits in experience-dependent cortical plasticity and sensory-discrimination learning in presymptomatic Huntington's disease mice, J Neurosci, 25, 3059, 10.1523/JNEUROSCI.4320-04.2005 McCaw, 2004, Structure, expression and regulation of the cannabinoid receptor gene (CB1) in Huntington's disease transgenic mice, Eur J Biochem, 271, 4909, 10.1111/j.1432-1033.2004.04460.x Murphy, 2000, Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington's disease mutation, J Neurosci, 20, 5115, 10.1523/JNEUROSCI.20-13-05115.2000 Naver, 2003, Molecular and behavioral analysis of the R6/1 Huntington's disease transgenic mouse, Neuroscience, 122, 1049, 10.1016/j.neuroscience.2003.08.053 Nicholson, 2002, Processing human brain tissue for in situ hybridization with radiolabelled oligonucleotides, 105 Nicholson, 1996, GABAA receptor subunit subtypes in the human putamen and globus pallidus in Huntington's disease—an in situ hybridisation study, 433 Nicholson LFB, Faull RLM (1999) Expression of GABAA receptor subunit mRNA's in the human thalamus. In: Abstract P10c Australian Neuroscience Society, 19th annual meeting. Nicniocaill, 2001, Altered striatal amino acid neurotransmitter release monitored using microdialysis in R6/1 Huntington transgenic mice, Eur J Neurosci, 13, 206, 10.1046/j.0953-816X.2000.01379.x Nithianantharajah, 2008, Gene-environment interactions modulating cognitive function and molecular correlates of synaptic plasticity in Huntington's disease transgenic mice, Neurobiol Dis, 29, 490, 10.1016/j.nbd.2007.11.006 Page, 2000, Effects of systemic 3-nitropropionic acid-induced lesions of the dorsal striatum on cannabinoid and mu-opioid receptor binding in the basal ganglia, Exp Brain Res, 130, 142, 10.1007/s002210050016 Pagotto, 2001, Normal human pituitary gland and pituitary adenomas express cannabinoid receptor type 1 and synthesize endogenous cannabinoids: first evidence for a direct role of cannabinoids on hormone modulation at the human pituitary level, J Clin Endocrinol Metab, 86, 2687 Pang, 2006, Differential effects of voluntary physical exercise on behavioral and brain-derived neurotrophic factor expression deficits in Huntington's disease transgenic mice, Neuroscience, 141, 569, 10.1016/j.neuroscience.2006.04.013 Richfield, 1994, Selective vulnerability in Huntington's disease: preferential loss of cannabinoid receptors in lateral globus pallidus, Ann Neurol, 36, 577, 10.1002/ana.410360406 Spires, 2004, Environmental enrichment rescues protein deficits in a mouse model of Huntington's disease, indicating a possible disease mechanism, J Neurosci, 24, 2270, 10.1523/JNEUROSCI.1658-03.2004 Starowicz, 2007, Biochemistry and pharmacology of endovanilloids, Pharmacol Ther, 114, 13, 10.1016/j.pharmthera.2007.01.005 Toth, 2005, Expression and distribution of vanilloid receptor 1 (TRPV1) in the adult rat brain, Brain Res Mol Brain Res, 135, 162, 10.1016/j.molbrainres.2004.12.003 Trottier, 1994, Instability of CAG repeats in Huntington's disease: relation to parental transmission and age of onset, J Med Genet, 31, 377, 10.1136/jmg.31.5.377 van Dellen, 2000, Delaying the onset of Huntington's in mice, Nature, 404, 721, 10.1038/35008142 Wilson, 2002, Neuroscience—endocannabinoid signaling in the brain, Science, 296, 678, 10.1126/science.1063545 Wisden, 2002